Serum soluble CD26 levels: diagnostic efficiency for atopic dermatitis, cutaneous T-cell lymphoma and psoriasis in combination with serum thymus and activation-regulated chemokine levels

Inhibition of CD26/Dipeptidyl Peptidase IV Enhances CCL11/Eotaxin-Mediated Recruitment of Eosinophils In Vivo

(2014) U. Forssmann et al.   JOURNAL OF IMMUNOLOGY

Eotaxins and CCR3 Interaction Regulates the Th2 Environment of Cutaneous T-Cell Lymphoma

(2010) Tomomitsu Miyagaki et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

On the origin of serum CD26 and its altered concentration in cancer patients

(2009) Oscar J. Cordero et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Plasma sCD26 and sCD30 levels in cutaneous leishmaniasis

(2008) R. Jafari-Shakib et al.   ACTA TROPICA

Distribution of dipeptidyl-peptidase IV on keratinocytes in the margin zone of a psoriatic lesion: a comparison with hyperproliferation and aberrant differentiation markers

(2008) R. G. van Lingen et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes

(2008) R.G. van Lingen et al.   BRITISH JOURNAL OF DERMATOLOGY

Reduced CD26bright expression of peripheral blood CD8+ T-cell subsets in psoriatic patients

(2008) Rosanne G. van Lingen et al.   EXPERIMENTAL DERMATOLOGY

Serum levels of soluble CD26 in patients with scleroderma

(2008) Zenshiro Tamaki et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function

(2008) Kei Ohnuma et al.   TRENDS IN IMMUNOLOGY